Advertisement

Topics

Historical Control In Psoriatic Arthritis May Hinge On Background Therapy

16:08 EDT 17 Aug 2017 | SCRIP

FDA says during meeting on Xeljanz application that it is interested in feedback on creating a control group for non-inferiority...

      

Related Stories

 

Original Article: Historical Control In Psoriatic Arthritis May Hinge On Background Therapy

NEXT ARTICLE

More From BioPortfolio on "Historical Control In Psoriatic Arthritis May Hinge On Background Therapy"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...